Overview

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

Status:
Terminated
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.
Phase:
Phase 4
Details
Lead Sponsor:
New York State Psychiatric Institute
Treatments:
Dextroamphetamine
Tranylcypromine